Clinical Trial Update: Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating memantine for efficacy and safety in dementia associated with Parkinson's disease and dementia with Lewy bodies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Parkinson Disease Dementia

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Helse Stavanger HF | Conditions: Dementia Associated With Parkinson's Disease, Dementia With Lewy Bodies | Phase 2 | Status: COMPLETED